HGXCX | RSLDX | HGXCX / RSLDX | |
Total Expense Ratio | 1.94 | 0.80 | 243% |
Annual Report Gross Expense Ratio | 1.99 | 0.80 | 249% |
Fund Existence | 8 years | 10 years | - |
Gain YTD | 11.505 | 9.758 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 250 | 800% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 312M | 80.3B | 0% |
Annual Yield % from dividends | 0.00 | 0.81 | - |
Returns for 1 year | 11.06 | 9.06 | 122% |
Returns for 3 years | 27.64 | 26.13 | 106% |
Returns for 5 years | 34.87 | 15.49 | 225% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FISEX | 34.32 | 0.02 | +0.06% |
Franklin Equity Income A | |||
NSOPX | 17.40 | -0.10 | -0.57% |
North Star Opportunity A | |||
GGZPX | 23.91 | -0.14 | -0.58% |
Goldman Sachs Enhanced U.S. Equity P | |||
RICBX | 64.09 | -0.46 | -0.71% |
American Funds Invmt Co of Amer R2 | |||
ETAHX | 36.37 | -0.50 | -1.36% |
Eventide Healthcare & Life Sciences A |